Iliopsoas Haematoma during Extracorporeal Membrane Oxygenation

Written By CCRG

A registry report from the COVID-19 Critical Care Consortium across 30 countries.

Taniguchi H, Rätsep I, Heinsar S, Liu K, Cespedes M, Suen JY, Li Bassi G, Fraser JF, Jacobs JP, Peek GJ. Perfusion DOI: 10.1177/02676591231168285

Abstract: Iliopsoas haematoma (IPH) during extracorporeal membrane oxygenation (ECMO) is a rare bleeding complication that can be fatal due to its progression to abdominal compartment syndrome, but its incidence and risk factors are not well known. We have previously reported an IPH incidence rate of 16% in Japan. Among possible reasons for this high incidence, ethnicity has been hypothesised to play a role. Therefore, we used an international multi-centre cohort registry to test this hypothesis by determining the incidence rate of IPH.

CCRG
Previous

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study
Next

Characteristics and outcomes of patients with severe COVID-19 in Indonesia: Lessons from the first wave